Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported
(AJANTAPHARMA)
XNSE:AJANTAPHARMA, XBOM:532331
Ajanta Pharma Ltd Q4FY24; 39% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Ajanta Pharma Ltd Q3FY24; 56% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Ajanta Pharma Ltd Q2FY24; 24% rise in Profits
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported
Ajanta Pharma Ltd Q1FY24; 19% rise in Profits.
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma Ltd reported
Ajanta Pharma Limited (AJANTPHARM) Q4 FY23 Earnings Concall Transcript
Ajanta Pharma Limited (NSE:AJANTPHARM) Q4 FY23 Earnings Concall dated May. 05, 2023. Corporate Participants: Yogesh Agrawal -- Managing Director Rajesh Agrawal -- Joint Managing Director Arvind
Earnings | Ajanta Pharma Ltd. (NSE: AJANTAPHARMA): Q4FY23 Results Out; Total Income rises 2.1% YoY.
Ajanta Pharma is a leading Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of high-quality specialty pharmaceutical finished dosages.
Ajanta Pharma Limited (NSE: AJANTAPHARMA): Q3 FY23 Results Out; Total Income Rises 17% YoY
Ajanta Pharma Limited (NSE: AJANTAPHARMA) is an Indian pharmaceutical company that specializes in the production and distribution of generic drugs. The company